NOVAVAX INC — Director's Dealing 2016

Feb 1, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2016-01-31

Reporting Person: Glenn Gregory M (SVP, Research and Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-01-31	Common Stock	P	2369	$4.38	Acquired	2427	Direct

Footnotes

F1: Includes 2,369 shares acquired under the Issuer's 2013 Employee Stock Purchase Plan on January 31, 2016.